Government and policy
Words cannot begin to describe the heartbreak of seeing a vacant expression etched across the face of a person once so full of vibrancy as they struggle to fathom out what is going on or why they feel in such a strange state of confusion.
We look at the role challenges ahead for the G8 Dementia Envoy, Dr Dennis Gillings.
The government have announced the intention to fast-track breakthrough drugs to seriously ill patients. Our Head of Policy and Public Affairs comments.
It’s been an exciting week for dementia. Like buses, you wait ages for exciting announcements from Government and then three come along at once!
Dr Matthew Norton, Head of Policy at Alzheimer’s Research UK talks about the cross-charity and parliamentary work on tackling the stigma of dementia
George Freeman MP blogs about the pioneering new dementia research in the UK, and the new way of thinking required for dementia healthcare.
The G8 set an ambitious goal to identify a cure for dementia by 2025; we look at the dementia research investment of the world’s top economies.
This week in London marks a pivotal moment in dementia research; it will either be considered a time of historical significance when global interests align under a banner of defeating dementia, or an instance in which a global health crisis was only superficially addressed by the world’s largest economies.
Up until now, there has been little mention of dementia research in the wider social care debate. Why is dementia research the elephant in the room?
This month we’ll be at the political party conferences urging all parties to continue to back dementia research. With no new drugs since 2003, and those in existence only showing modest efficacy, we desperately need new treatments that can delay the onset, slow the progression and manage the symptoms of dementia.